European Vaccine Initiative
🇬🇧United Kingdom
Clinical Trials
7
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:5
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (83.3%)Not Applicable
1 (16.7%)A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate
Not Applicable
Not yet recruiting
- Conditions
- Malaria Fever
- Interventions
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- European Vaccine Initiative
- Target Recruit Count
- 24
- Registration Number
- NCT07124156
Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- European Vaccine Initiative
- Target Recruit Count
- 69
- Registration Number
- NCT06618885
- Locations
- 🇧🇫
Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
Evaluation of Electronic Pregnancy Registers and Mobile Applications for Monitoring Pregnancy Outcomes ( EVAPREAP )
Completed
- Conditions
- Pregnancy Related
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- European Vaccine Initiative
- Target Recruit Count
- 2000
- Registration Number
- NCT06225739
- Locations
- 🇧🇯
Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin
🇧🇫Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
🇬🇭Kintampo Health Research Centre (KHRC), Kintampo, Ghana
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers
Phase 1
Completed
- Conditions
- Plasmodium Falciparum Malaria
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2008-08-08
- Lead Sponsor
- European Vaccine Initiative
- Target Recruit Count
- 56
- Registration Number
- NCT00730782
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
🇳🇱Biomedical Primate Research Centre, Rijswijk, Netherlands
GMZ2-Aluminum Hydroxide Phase I, Tübingen
Phase 1
- Conditions
- Malaria
- First Posted Date
- 2006-11-09
- Last Posted Date
- 2007-08-10
- Lead Sponsor
- European Vaccine Initiative
- Target Recruit Count
- 30
- Registration Number
- NCT00397449
- Locations
- 🇩🇪
Institut for Tropical Medicine, University of Tubingen, Tubingen, Germany
- Prev
- 1
- 2
- Next
News
No news found